HomeBUSINESS
BUSINESS

Taisho Files Taurine for Recurrence Prevention of Stroke-Like Episodes in MELAS in Japan
(Apr.17.2018)

Taisho Pharmaceutical said on April 16 that it has filed an application seeking to expand the treatment scope of Taurine powder 98% “Taisho” to include the recurrence prevention of stroke-like episodes in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) ...
(LOG IN FOR FULL STORY)